Delayed Diagnosis of Cardiac Amyloidosis Secondary to Multiple Myeloma.

Cardiac amyloidosis Congestive heart failure Multiple myeloma

Journal

Journal of medical cases
ISSN: 1923-4163
Titre abrégé: J Med Cases
Pays: Canada
ID NLM: 101551824

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 05 07 2021
accepted: 14 08 2021
entrez: 25 10 2021
pubmed: 26 10 2021
medline: 26 10 2021
Statut: ppublish

Résumé

Cardiac amyloidosis is a rare condition with only 2,500 new cases reported yearly in the United States of America (USA). The prognosis of cardiac amyloidosis is particularly grim. The median survival is 6 months from onset of congestive heart failure (CHF) symptoms. CHF is a common presentation as the second leading cause of hospitalization in the senile population in the USA. We report a case of an 83-year-old man who presented with the classic symptoms of CHF including bilateral lower extremity edema, shortness of breath, and weight gain. Upon further workup, an echocardiogram revealed strain patterns suggestive of cardiac amyloidosis and bone marrow biopsy confirmed the diagnosis of multiple myeloma. Unfortunately, despite starting treatment with steroids and chemotherapy, the patient succumbed to his condition in a matter of weeks. We report this case to highlight that cardiac amyloidosis secondary to multiple myeloma can present in the form of new onset, quickly deteriorating CHF long before any classic multiple myeloma symptoms manifest.

Identifiants

pubmed: 34691334
doi: 10.14740/jmc3744
pmc: PMC8510665
doi:

Types de publication

Case Reports

Langues

eng

Pagination

391-394

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

Copyright 2021, Qatanani et al.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest for this publication.

Références

Blood Adv. 2017 Jan 4;1(4):282-287
pubmed: 29296944
Mayo Clin Proc. 2010 Mar;85(3):232-8
pubmed: 20194151
BMC Cancer. 2016 Feb 25;16:159
pubmed: 26915519
Leukemia. 2009 Jan;23(1):3-9
pubmed: 18971951
Bone Marrow Transplant. 2006 Jul;38(1):7-15
pubmed: 16715110
Clin Exp Nephrol. 2012 Oct;16(5):659-71
pubmed: 22968855
Sci Rep. 2019 Jun 12;9(1):8552
pubmed: 31189919
Leukemia. 2009 Jul;23(7):1337-41
pubmed: 19225538
Indian J Nephrol. 2016 Nov-Dec;26(6):467-469
pubmed: 27942184
JAMA Oncol. 2018 Sep 1;4(9):1221-1227
pubmed: 29800065
Medicine (Baltimore). 2017 Dec;96(50):e8771
pubmed: 29390268
Korean Circ J. 2013 Nov;43(11):752-60
pubmed: 24363751
Circ Cardiovasc Imaging. 2018 May;11(5):e006588
pubmed: 29752392
Trends Cardiovasc Med. 2018 Jan;28(1):10-21
pubmed: 28739313

Auteurs

Ahmad Qatanani (A)

Department of Medicine, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.

Shereen Dahab (S)

Department of Medicine, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.

Steven Douedi (S)

Department of Medicine, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.

Yumna Hamid (Y)

Department of Medicine, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.

Sameh Girgis (S)

Department of Medicine, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.

Steven Daniels (S)

Department of Cardiology, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.

Gurpreet Lamba (G)

Department of Hematology & Oncology, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.

Mohammad Zafar (M)

Department of Nephrology, Jersey Shore University Medical Center, Neptune, NJ 07753, USA.

Classifications MeSH